Remove .Net Remove News Remove Pricing Remove Technical Review
article thumbnail

How long can Zuckerberg afford to bankroll the AR/VR market?

TechCrunch LA

Hello friends, and welcome back to Week in Review ! The company’s stock tanked by more than 26 percent, representing a $230 billion reduction in market cap and a $31 billion drop in Zuckerberg’s personal net worth. Last week, we talked about about the “de-stonkifying” of the market. Image Credits: Facebook.

Marketing 246
article thumbnail

Bio Roundup: FDA Says No, PCSK9 Value Fight, CRISPR Intrigue & More

Xconomy

And once in a while, a defender uses his or her face, inadvertently, to block a ball spiked over the net. The CRISPR news this week doesn’t need a metaphor; the drama that MIT Technology Review reported can stand alone. Here’s more on Radius’s drug and osteoporosis care from the New York Times.

Insiders

Sign Up for our Newsletter

This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.

article thumbnail

What Do LPs Think of the Venture Capital Markets for 2016?

Both Sides of the Table

We All Know That Dollars into Venture Have Gone Up … As a starting point, we know that the dollars into venture have steadily rebounded to pre great-recession levels, with just under $30 billion committed to US technology venture capital in 2015. …But LPs Have Been Putting Out More Money Than They Are Getting Back.

article thumbnail

Tech Titans Peter Thiel, Matt Jacobson, Cameron and Tyler Winklevoss, Mich Mathews, Elon Musk Buy Homes in Los Angeles

SoCal Delicious

Financial News. Loading… New York. Loading… Tech. SIGNIFICANCE PASSING-MENTION. --> Tech Titans Hit the Beach As Silicon Valley moguls go on a home-buying spree in Los Angeles, theyre reshaping the real-estate landscape. The tech industry is going south. MarketWatch. MarketWatch. AllThingsDigital.

article thumbnail

Bio Roundup: Clinical Shirkers, AMD Worriers, ASH Fallers & More

Xconomy

Our previous roundup came out last week before news broke that Susan Lindquist, a highly decorated and thoughtful researcher into the inner workings of proteins, passed away. —The new wave of so-called PCSK9 drugs to treat high cholesterol, once expected to flood the market , have barely caused a ripple. She was 67.